EMA — authorised 13 April 2022
- Marketing authorisation holder: ASTELLAS PHARMA EUROPE B.V.
- Status: approved
🇪🇺 Enfortumab in European Union
EMA authorised Enfortumab on 13 April 2022
Marketing authorisation
Enfortumab in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Enfortumab approved in European Union?
Yes. EMA authorised it on 13 April 2022.
Who is the marketing authorisation holder for Enfortumab in European Union?
ASTELLAS PHARMA EUROPE B.V. holds the EU marketing authorisation.